Bioethics of intervention and the case of drugs Bevacizumab and Ranibizumab for retinal diseases. Revista Iberoamericana de Bioética, [S. l.], n. 2, p. 1–10, 2016. DOI: 10.14422/rib.i02.y2016.004. Disponível em: https://revistas.comillas.edu/bioetica-revista-iberoamericana/article/view/7346. Acesso em: 5 dec. 2025.